OLY1:FRA
Olympus Corp
11,18 €
arrow_upward
+0,18%(+0,020) 1D
12 tet, 8:03:22 p.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për OLY1...
Hap
11,18 €
I lartë
11,18 €
I ulët
11,18 €
Kapitalizimi i tregut
14,12Â mld
Vëllimi mesatar
4,00
Vëllimi
350,00
Maksimumi 52-javor
11,74 €
Minimumi 52-javor
7,01 €
Numri i punonjësve
28 mijë
Hap
11,18 €
I lartë
11,18 €
I ulët
11,18 €
Kapitalizimi i tregut
14,12Â mld
Vëllimi mesatar
4,00
Vëllimi
350,00
Maksimumi 52-javor
11,74 €
Minimumi 52-javor
7,01 €
Numri i punonjësve
28 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
PR Newswire
·
33 minuta më parë
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)
GlobeNewswire
·
33 minuta më parë
Stewards Inc. to Ring Nasdaq Opening Bell on Oct. 14, Celebrating Company's Next Chapter
Yahoo Finance
·
26 minuta më parë
A handful of tech stocks are masking an ugly S&P 500 problem
Kansas City Star
·
23 minuta më parë
Wall St steady at open as oil jumps ahead of key earnings
Profili
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation.
Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
Rreth Olympus Corp
Drejtori ekzekutivYasuo Takeuchi
Punonjësit28,1 mijë
Themeluar më12 tet 1919
Selia-
SektoriMedical device
Uebsajtiolympus.co.jp